More than six years into the Covid pandemic, long Covid continues to affect millions of people despite the broader conclusion that the public health emergency has passed. Researchers at University College London and University College London Hospitals conducted a new clinical trial examining potential treatments for the condition.
The trial investigated the effectiveness of over-the-counter antihistamines combined with colchicine, a prescription anti-inflammatory medication. Results indicated these treatments produced a small reduction in fatigue symptoms among long Covid patients. However, researchers cautioned that while the findings represent progress in understanding treatment options, the intervention does not constitute a cure for the condition. Professor Danny Altmann, an immunologist at Imperial College London, discussed the implications of this research and highlighted the broader challenges surrounding long Covid comprehension and management.
Beyond the new trial results, upcoming studies are expected to provide additional insights into long Covid. Researchers and medical professionals continue working to better understand the condition’s mechanisms and develop more effective treatment approaches.
In separate health-related developments, data indicated that approximately one in 335 people in the United Kingdom live with a stoma. According to Colostomy UK, more than 60 per cent of individuals with a stoma report that inadequate toilet facilities negatively impact their quality of life. Following a campaign originating in Bristol, the retailer B&Q modified disabled toilet facilities across its stores to be stoma-friendly, representing an effort to improve accessibility for affected individuals.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI